sulfoxide has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HJ; Gong, B; Li, RS; Liu, C; Tian, CC; Wang, DJ; Xu, TS; Xue, YX; Yue, LJ; Zhou, Q; Zhu, XY | 1 |
1 other study(ies) available for sulfoxide and Cardiovascular Stroke
| Article | Year |
|---|---|
S‑allyl‑cysteine sulfoxide (alliin) alleviates myocardial infarction by modulating cardiomyocyte necroptosis and autophagy.
Topics: Animals; Apoptosis; Autophagy; Cell Survival; Cysteine; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Necroptosis; Receptor-Interacting Protein Serine-Threonine Kinases; Safrole; Signal Transduction | 2019 |